Localization of glycosaminoglycans (GAGs) in pleomorphic adenoma (PA) of salivary glands: an immunohistochemical and histochemical evaluation.
The tumor matrix of salivary pleomorphic adenoma (PA) is characteristically rich in glycosaminoglycans (GAGs), which contribute to its complex histoarchitecture. This study evaluated the microscopic localization of various GAGs in 17 PAs, using a panel of anti-GAG monoclonal antibodies and biotinylated hyaluronic acid (HA)-binding protein. Both epithelial and mesenchymal-like tissues were confirmed to contain GAGs. Luminal epithelial cells mostly lacked GAGs, whereas GAGs were seen both in the cytoplasm and cell membrane of non-luminal epithelial cells. In addition, small intercellular accumulations of GAGs were often present in solid epithelial areas, implying the epithelial origin of GAGs. GAGs did not appear to be a main component of the hyaline matrix. The myxoid region was consistently stained for both chondroitin 6-sulfate (CS-6) and HA but variably for chondroitin 4-sulfate (CS-4), dermatan sulfate (DS) and keratan sulfate (KS); heparan sulfate (HS) was not detected. The chondroid region showed increased staining for CS-6 but reduced staining for HA when compared with the myxoid region. In addition, CS-4, DS and KS were seen both in chondroid cells and the territorial matrix, whereas HS was present only in the cells. It is suggested that GAGs in PA are mainly produced by non-luminal cells and influence the proliferation, differentiation, secretory activity and shape of tumor cells, thus contributing to the morphological diversity of this tumor.
Zhao
M
M
Department of Oral Pathology, Hiroshima University School of Dentistry, Japan.
Takata
T
T
Ogawa
I
I
Miyauchi
M
M
Ito
H
H
Nikai
H
H
D008949:Adenoma, Pleomorphic / Q000737:chemistry / Q000473:pathology*; D000911:Antibodies, Monoclonal; D002454:Cell Differentiation; D002455:Cell Division; D002462:Cell Membrane / Q000737:chemistry / Q000648:ultrastructure; D048429:Cell Size; D002809:Chondroitin Sulfates / Q000032:analysis; D003593:Cytoplasm / Q000737:chemistry / Q000648:ultrastructure; D003871:Dermatan Sulfate / Q000032:analysis; D004847:Epithelial Cells / Q000737:chemistry / Q000473:pathology; D004848:Epithelium / Q000737:chemistry / Q000473:pathology; D005109:Extracellular Matrix / Q000737:chemistry / Q000648:ultrastructure; D006025:Glycosaminoglycans / Q000032:analysis*; D006497:Heparan Sulfate / Q000032:analysis; D006651:Histocytochemistry; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis; D007150:Immunohistochemistry; D007632:Keratan Sulfate / Q000032:analysis; D008648:Mesoderm / Q000737:chemistry / Q000473:pathology; D012468:Salivary Gland Neoplasms / Q000737:chemistry / Q000473:pathology*
D000911:Antibodies, Monoclonal; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D006820:Hyaluronic Acid; D007632:Keratan Sulfate